EMQN closely tracks developments in diagnostic testing as new technologies are adopted and applied. EMQN responds to these developments with new EQA schemes, providing support to progressive laboratories. Participating laboratories benefit from an independent measure of quality early in the adoption process.
An example of EMQN leadership is in the development of sequencing schemes. Other schemes currently under consideration include the development of EQA methodologies for:
- New sequencing technologies
- Prenatal diagnostics
- Pharmacogentics method to predict patient response to new specialized drugs
Join Now
